Phytopharm PLC
26 January 2005
Not for release, publication or distribution, directly or indirectly, in or into
the United States, Canada, Australia, Japan or the Republic of Ireland
For immediate release
Phytopharm plc
The Board of Phytopharm plc (the 'Company') notes the recent share price
movement and press speculation.
The Company confirms that following recent positive events it is in advanced
discussions to raise additional finance by way of a material equity placing and
open offer to further develop and exploit the potential of its product
candidates.
Enquiries:
Financial Dynamics
David Yates/Ben Atwell
Tel: +44 20 7831 3113
These written materials are not for distribution in the United States. These
written materials are not an offer of securities for sale in the United States.
Securities may not be offered or sold in the United States absent registration
under the US Securities Act or an exemption therefrom. Phytopharm plc has not
and does not intend to register any of the securities under the US Securities
Act. The securities will not be offered or sold to the public in the United
States of America.
This information is provided by RNS
The company news service from the London Stock Exchange
SPMSESFEMSISEEF
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.